Among them, MAPK and PI3K/Akt are also an important pathways in inflammation, and studies have shown that anti-angiogenic effect of Shikonin in RA by downregulating PI3K/AKT and MAPKs signaling pathways (Liu et al., 2020). Here, AKT1 is linked to rheumatoid arthritis.